RE:RE:RE:RE:Peak Sales of MCNA and potential. RRube, I apologize but I missed the entirety of your post waiting to catch my train. When you speak of Dr. Morales authoring this journal article are you speculating or is that a fact? I had thought that Dr. Morales had retired a few years ago and was more or less washed aside with the management change. I am not sure whether new shareholders are aware, but Dr. Morales was instrumental in pioneering the current BCG treatment for bladder cancer and was a pivotal voice endorsing and promoting widespread use. The weight that he carries as a champion for Urocidin, its replacement, or alternative in its absence is enormous and it would be wonderful if he were still an advocate of urocidin's approval. Several years ago I met a urologist while golfing in the US. After a short discussion I realized hat he had never heard of, and had no interest in Bioniche. When I mentioned Dr. Morales involvement he changed his tune 180 degrees and mentioned that he had studied under him in the 1970s. He described him as one of the urology field's most respected thinkers and used a couple of terms I recall, including unconventional and extremely influential . It would be good for all involved if he were both able and willing to participate in this Urocidin article.